Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Aims: Biliary atresia (BA) is a congestive biliary disease that develops in the neonatal period or early infancy. It may present with portal hypertension and varices needing treatment (VNT) even after successful Kasai portoenterostomy. This study aimed to stratify the risk of VNT in children and adolescents with BA.

Methods: In this prospective cross-sectional study, we measured liver stiffness (LS) and spleen stiffness (SS) by two-dimensional shear wave elastography and checked for VNT endoscopically in 53 patients with BA who attended for follow-up between July 2018 and September 2022. Varices needing treatment were defined as large esophageal varices, esophageal varices of any size with red color signs, and/or gastric varices along the cardia.

Results: Twenty-five patients (aged 0-18 years) had VNT. Eighteen patients met the Baveno VI criteria (LS <20 kPa; platelet count >150 000/L) and were deemed to be at low risk of VNT (spared endoscopies) while three had missed VNT (16.7%). Applying the Baveno VII criteria, which combines the SS cut-off value of 40 kPa with the Baveno VI criteria, resulted in five missed VNTs among 22 spared endoscopies (22.7%). A modification of the Baveno VII criteria using the aspartate aminotransferase-to-platelet ratio index (APRI) instead of the platelet count with cut-off values of 25 kPa, 30 kPa, and 1.04 for LS, SS, and APRI, respectively, missed only one VNT (5.0%) among 20 spared endoscopies.

Conclusions: A novel diagnostic criterion that combines LS, SS, and APRI reduced the risk of missing VNT to 5% in children and adolescents with BA.

Download full-text PDF

Source
http://dx.doi.org/10.1111/hepr.13976DOI Listing

Publication Analysis

Top Keywords

varices needing
12
needing treatment
12
baveno vii
12
vii criteria
12
aspartate aminotransferase-to-platelet
8
aminotransferase-to-platelet ratio
8
spleen stiffness
8
biliary atresia
8
modification baveno
8
vnt
8

Similar Publications

Background And Aims: Portal hypertension is the principal driver of cirrhosis decompensation, leading to heightened morbidity and mortality. While non-selective beta-blockers (NSBBs) remain the standard of care, up to 45% of patients fail to achieve sufficient portal pressure reduction. Statins have gained attention as a potential therapeutic agent for portal hypertension.

View Article and Find Full Text PDF

Completely Occlusive Portal Vein Thrombosis as a Predictor of Mortality in Acute Variceal Bleeding.

Liver Int

October 2025

Department of Gastroenterology and Hepatology, Laboratory of Gastrointestinal Cancer and Liver Disease, West China Hospital, Sichuan University, Chengdu, China.

Background: Risk stratification plays a critical role in acute variceal bleeding (AVB) management, while portal vein thrombosis (PVT) has uncertain prognostic significance in AVB.

Aim: This study aimed to investigate the impact of PVT on the prognosis of patients with cirrhosis and AVB, with a particular focus on the influence of PVT severity stratification.

Methods: A retrospective analysis was conducted on 1389 cirrhotic patients with PVT (n = 292, 21.

View Article and Find Full Text PDF

IntroductionPost-operative venous thromboembolism (VTE) remains a significant concern after endovenous ablation (EVA) for varicose veins. Risk stratification tools aid identifying which patients have an increased VTE risk. There is no consensus on which currently utilised score is most appropriate for daycase surgery.

View Article and Find Full Text PDF

Liver cirrhosis is associated with serious complications of portal hypertension (PH), which ultimately causes variceal bleeding and ascites in a life-threatening manner. Non-invasive diagnostic techniques have evolved as an essential tool of early detection and management from a stand point of being dependent on invasive diagnostic techniques. This review summarises the most recent progress in noninvasive diagnostic possibilities in PH in liver cirrhosis in terms of its clinical use and future outlook.

View Article and Find Full Text PDF

Background And Study Aims: Endoscopic spray therapy has been shown to be effective and safe in managing upper gastrointestinal bleeding (UGIB). We aimed to evaluate safety and efficacy of the novel powder-based Resolv Endoscopic Hemostat System in managing UGIB.

Patients And Methods: This was a single-center, prospective, single-arm study conducted from July 2022 to February 2023.

View Article and Find Full Text PDF